King Sarah, Exley Josephine, Taylor Jirka, Kruithof Kristy, Larkin Jody, Pardal Mafalda
Rand Health Q. 2016 Jan 29;5(3):2.
RAND Europe undertook a systematic review of the evidence of effectiveness and cost effectiveness on changing the public's risk related behaviour pertaining to antimicrobial use to inform the development of a NICE public health guideline aimed at delaying antimicrobial resistance (AMR). The review considered educational interventions targeting individuals, communities or the general public delivered via any mode. Specifically, it aimed to address: 1. Which educational interventions are effective and cost-effective in changing the public's behaviour to ensure they only ask for antimicrobials when appropriate and use them correctly? 2. Which educational interventions are effective and cost-effective in changing the public's behaviour to prevent infection and reduce the spread of antimicrobial resistance? Overall, 60 studies met the inclusion criteria; 29 related to research question 1, and 36 related to research question 2 (five studies were applicable to both). The key findings are summarised in "Evidence Statements" in accordance with NICE guidelines. Evidence Statements provide a high level overview of the key features of the evidence including: the number of studies, the quality of evidence, and the direction of the estimated effect followed by a brief summary of each of the supporting studies. Studies are grouped into Evidence Statements by setting and intervention.
兰德欧洲公司对改变公众与抗菌药物使用相关的风险行为的有效性和成本效益证据进行了系统综述,以为制定旨在延缓抗菌药物耐药性(AMR)的英国国家卫生与临床优化研究所(NICE)公共卫生指南提供信息。该综述考虑了通过任何方式针对个人、社区或公众开展的教育干预措施。具体而言,其旨在解决以下问题:1. 哪些教育干预措施在改变公众行为以确保他们仅在适当的时候索要抗菌药物并正确使用方面是有效且具有成本效益的?2. 哪些教育干预措施在改变公众行为以预防感染和减少抗菌药物耐药性传播方面是有效且具有成本效益的?总体而言,60项研究符合纳入标准;29项与研究问题1相关,36项与研究问题2相关(5项研究适用于两者)。关键研究结果按照NICE指南总结在“证据声明”中。证据声明提供了证据关键特征的高层次概述,包括:研究数量、证据质量以及估计效应的方向,随后是对每项支持性研究的简要总结。研究按背景和干预措施分组纳入证据声明。